Vectus Biosystems (ASX:VBS) Total Payout Yield %

: 0.00 (As of Today)

View and export this data going back to 2016. Start your Free Trial

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Vectus Biosystems's current Total Payout Yield % is 0.00%.

Vectus Biosystems Total Payout Yield % Historical Data

The historical data trend for Vectus Biosystems's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Total Payout Yield %

-16.12

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Total Payout Yield %										-36.26	-	-	-	-23.52

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Vectus Biosystems Total Payout Yield % Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Total Payout Yield % falls in comparison to its industry or sector. The grey bar indicates the Total Payout Yield %'s extreme value range as defined by GuruFocus.

Vectus Biosystems Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Vectus Biosystems's Total Payout Yield % for the fiscal year that ended in Jun. 2022 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Market Cap
	=	- (0	+	0	+	0)	/	35.7197445
	=	0.00%

Vectus Biosystems's annualized Total Payout Yield % for the quarter that ended in Dec. 2022 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	*	Annualized Factor	/	Market Cap
	=	- (-0.034	+	4.601	+	0)	*	2	/	38.828335
	=	-23.52%

Vectus Biosystems Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

Vectus Biosystems Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Total Payout Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018

Website

http://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines